phenylsaligenin cyclic phosphate has been researched along with verapamil in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ehrich, M; el-Fawal, HA; Jortner, BS | 1 |
Ehrich, M; Lee, JC; McCain, WC; Wilcke, J | 1 |
Ehrich, MF; el-Fawal, HA | 1 |
3 other study(ies) available for phenylsaligenin cyclic phosphate and verapamil
Article | Year |
---|---|
Modification of phenyl saligenin phosphate-induced delayed effects by calcium channel blockers: in vivo and in vitro electrophysiological assessment.
Topics: Acetylcholine; Animals; Calcium Channel Blockers; Chickens; Electrophysiology; Female; In Vitro Techniques; Muscle Contraction; Neuromuscular Junction; Neurotoxins; Nifedipine; Organophosphorus Compounds; Reference Values; Sciatic Nerve; Tibial Nerve; Verapamil | 1990 |
Effect of cyclic phenyl saligenin phosphate and paraoxon treatment on vascular response to adrenergic and cholinergic agents in hens.
Topics: Adrenergic Agents; Animals; Brain; Carboxylic Ester Hydrolases; Chickens; Cholinergic Agents; Drug Interactions; Female; Hemodynamics; Insecticides; Motor Activity; Organophosphorus Compounds; Paraoxon; Random Allocation; Regional Blood Flow; Verapamil | 1995 |
Calpain activity in organophosphorus-induced delayed neuropathy (OPIDN): effects of a phenylalkylamine calcium channel blocker.
Topics: Analysis of Variance; Animals; Biomarkers; Calcium; Calpain; Chickens; Esterases; Female; Insecticides; Muscles; Neurons; Neurotoxins; Organophosphorus Compounds; Sciatic Nerve; Tritolyl Phosphates; Verapamil | 1993 |